Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies. [electronic resource]
Producer: 20071004Description: 3605-10 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
- Area Under Curve
- Carboplatin -- administration & dosage
- Female
- Humans
- Hydroxamic Acids -- administration & dosage
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Vorinostat
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.